Noninvasive blood-pressure measurement to estimate liver portal pressure
Part of Digestive system clinical trials.
This Phase 3 study tests a noninvasive ultrasound-based method to estimate portal hypertension, which is high blood pressure in the liver’s blood vessels. It aims to help doctors measure how severe the liver circulation problem is without needing invasive pressure testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and medically stable
- Be able to follow study steps (mentally aware and able to consent)
- If you could become pregnant, have a negative pregnancy test before any study testing
- For most groups: have a confirmed diagnosis of portal hypertension
- Depending on your group, be scheduled for the matching procedure or treatment (biopsy, surveillance, starting beta-blockers, or endoscopy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new ultrasound technique called SHAPE to see if it can detect high blood pressure in the liver (portal hypertension) without needing an invasive procedure. It may help people who are already scheduled for a standard liver pressure measurement.
This trial compares a newer, less invasive method (using an endoscope) to measure pressure in the liver's blood vessels with the standard technique. It may help people with liver disease or suspected cirrhosis better understand their condition.
This trial uses a minimally invasive ultrasound technique to directly measure blood pressure in the liver's main vein. It may help doctors decide if patients with severe scarred livers need medication to prevent variceal bleeding.
This early-phase study tests a technique to measure blood pressure changes in people with cirrhosis (scarring of the liver). It may help doctors better understand liver circulation problems and guide safer treatment decisions.
This trial looks at people with clinically significant portal hypertension, which is high blood pressure in the liver's blood vessels. It may help find better ways to manage this condition.
This study compares a newer, less invasive method using an endoscope (EUS-PPG) with a standard catheter method (HVPG) to measure liver pressure in people with advanced liver disease. The goal is to see if the newer method is equally accurate and safer.
Hear when a new Liver Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.